We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





New Assay Detects Brazilian and South African SARS-CoV-2 Variants Faster than Sequencing, Screens More Samples

By LabMedica International staff writers
Posted on 12 Mar 2021
SeqOnce Biosciences (Pasadena, CA, USA) has launched its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 E484K variant at a faster rate than sequencing with the ability to screen more samples.

The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR E484K kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene E484K (G23012A), and includes RNaseP as a control. More...
The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX. Using RT-qPCR to detect the SARS-CoV-2 E484K variant is faster and allows far more samples to be screened, compared to sequencing. The AzureSeq E484K assay quickly identifies a mutation found in SARS-CoV-2 variants SA B.135.1 and Brazil P.1, which have been labeled as "variants of concern" by the CDC due to the potential to impact vaccine efficacy, and which may also be more infectious. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR E484K Assay is currently for Research Use Only.

"The release of the AzureSeq E484K assay is an important addition to our recently launched AzureSeq N501Y assay. While sequencing is the gold standard, using the AzureSeq RT-qPCR assays will screen far more samples for these Variants of Concern, and will do it in less than an hour - compared to two days," said Joe Dunham, CSO of SeqOnce.

"We anticipate teams using the AzureSeq assays to screen for these Variants of Concern will have reduced barriers. The assays work on conventional qPCR instruments that are wide-spread, and do not require specialized knowledge in sequencing," added Chris Angermayer, CEO of SeqOnce Biosciences. "Basically, if a lab can run a qPCR SARS-CoV-2 assay, they can also now screen for these variants."

Related Links:
SeqOnce Biosciences


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining Management Software
DakoLink
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.